The Paper's inquiry on September 16 found that Wuhan University’s official website had released information as early as May 6 that Li Hongliang was removed from the post of director of the Animal Experiment Center of Wuhan University and the director of the ABSL-Ⅲ laboratory of Wuhan University.
Recently, it was reported on the Internet that Li Hongliang, the dean of the School of Basic Medicine of Wuhan University, who was involved in the "Primary School Students Study Drinking Tea and Anti-cancer and Won the Third Prize of the National Competition", has been removed from the Institute of Model Animals and Director of the Model Animal Collaborative Innovation Center. He took the initiative to resign from the post of Dean of the School of Basic Medical Sciences of Wuhan University on September 15.
Li Hongliang is the father of the aforementioned two primary school students.
In response to information on job changes transmitted online, a staff member in Li Hongliang's office told The Paper that he needed to contact the Party Committee Propaganda Department to find out the situation; the staff of the Party Committee Propaganda Department of Wuhan University said that they needed to send an official letter to interview.
The staff of the Human Resources Office of the School of Basic Medical Sciences said, "It is not convenient to answer."
The Paper also inquired and found that Wuhan University issued a news on August 28 that, entrusted by the Organization Department of the Party Committee of the school, the Audit Office of Wuhan University decided to send an audit team, starting from September 1st, to assume financial responsibility for Li Hongliang, Dean of the School of Basic Medicine. Audit, the audit period is from December 20, 2016 to July 31, 2020.
The Paper previously reported that in mid-July, two elementary school students in Wuhan won the third prize of the National Youth Science and Technology Innovation Competition, the work "The Anti-tumor Experimental Research of Tea Polyphenols" was suspected of fraud.
The experiment involves tumor stripping and injection of tumor cells into nude mice.
Netizens questioned that the project requires researchers to conduct mouse experiments, and the experiment requires high logic, which is difficult for elementary school students to complete.
Experts in related fields from a university in Hunan also told The Paper that tea polyphenols have been reported for anti-cancer, and there are a lot of documents at home and abroad.
From a professional point of view, the innovation of the research project is very general.
Judging from the only public information, its substantial value is also very general.
In addition, Li Hongliang's team was involved in academic fraud in 2017.
According to the previous report of The Paper, the question mainly revolved around Li Hongliang's two papers published in Nature-Medicine in February and May 2017: ("Targeting CFLAR to improve non-alcoholic fat in mice and non-human primates "Hepatitis" and "Multivesicular body regulatory protein Tmbim1 improves non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4." Wuhan University reported to The Paper in January 2018 that the academic committee of the school believed : There is no academic fraud in the relevant content reported by Li Hongliang’s team, but there are individual omissions in the writing of the paper. It is recommended to be more rigorous and meticulous in the future.
According to the official website of Wuhan University School of Basic Medicine, Li Hongliang is a doctoral supervisor, currently the dean of the School of Basic Medicine, the director of the Institute of Model Animals of Wuhan University, the deputy director of the Institute of Cardiovascular Diseases of Wuhan University, and the director of the Medical Science Research Center of Zhongnan Hospital.
Winner of the National Outstanding Youth Fund, young and middle-aged scientific and technological innovation leader of the Ministry of Science and Technology, national "Ten Thousand Talents Program" leader; disciplines: internal medicine (cardiovascular disease), biomedical engineering; research direction for cardiovascular and cerebrovascular metabolic diseases Mechanism and prevention, research and development of genetic engineering animal models.
Reporter Zhu Xuan Yu Yan Zhu Lei